But the European drugs are extremely popular here in the U.S. Wegovy – the version of the drug that’s FDA-approved to treat ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Novo Nordisk has struggled to adapt to very high demand and a market where celebrities are more influential than doctors.

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Entrepreneurship raises your risk of obesity, but small changes to your diet can have similar affects to new weight-loss ...

Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...